Thomas C King's Insider Trades & SAST Disclosures
Thomas C King's most recent trade in GCT Semiconductor Holding Inc. was a trade of 30,000 Class A Common Stock done . Disclosure was reported to the exchange on Nov. 16, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Thomas C King.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GCT Semiconductor Holding ... | Thomas C. King | Director | 16 Nov 2023 | 30,000 | 30,000 | - | - | Class A Common Stock | ||
| GCT Semiconductor Holding ... | Thomas C. King | Director | 16 Nov 2023 | 30,000 | 0 | - | - | Class B Common Stock | ||
| Medpace Holdings Inc | Thomas C King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 1,903 | 1,903 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Medpace Holdings Inc | Thomas C King | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2021 | 500 | 2,021 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Medpace Holdings Inc | Thomas C King | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.63 per share. | 03 Nov 2021 | 500 | 774 (0%) | 0% | 75.6 | 37,815 | Common Stock |
| Medpace Holdings Inc | Thomas C King | Director | Sale of securities on an exchange or to another person at price $ 226.63 per share. | 03 Nov 2021 | 176 | 598 (0%) | 0% | 226.6 | 39,887 | Common Stock |
| Medpace Holdings Inc | Thomas C King | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jul 2021 | 500 | 2,521 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Medpace Holdings Inc | Thomas C King | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.63 per share. | 29 Jul 2021 | 500 | 500 (0%) | 0% | 75.6 | 37,815 | Common Stock |
| Medpace Holdings Inc | Thomas C King | Director | Sale of securities on an exchange or to another person at price $ 175.74 per share. | 29 Jul 2021 | 226 | 274 (0%) | 0% | 175.7 | 39,717 | Common Stock |
| Medpace Holdings Inc | Thomas C King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 1,822 | 1,822 | - | - | STOCK OPTION (RIGHT TO BUY) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges